The Effect of Informative Letters on the Prescription and Receipt of Seroquel

NACompletedINTERVENTIONAL
Enrollment

5,055

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

April 30, 2017

Conditions
EconomicsFraudDelivery of Health CareHealth ExpendituresCenters for Medicare and Medicaid Services (U.S.)
Interventions
OTHER

Placebo letter

The placebo letter describes a new rule in Medicare that requires prescribers to enroll in Medicare

OTHER

Initial Informative letter

The intervention is a letter that describes the Seroquel prescribing activity of the individual in comparison to a peer group of similar prescribers. It highlights the fact that the prescriber's activity is highly unlike her peers.

OTHER

Followup Informative Letter

The followup informative letter is identical to the initial informative letter except it provides an update on more recent prescribing rather than a description of earlier prescribing.

All Listed Sponsors
collaborator

Centers for Medicare and Medicaid Services

FED

collaborator

General Services Administration (GSA)

FED

lead

Abdul Latif Jameel Poverty Action Lab

OTHER

NCT02467933 - The Effect of Informative Letters on the Prescription and Receipt of Seroquel | Biotech Hunter | Biotech Hunter